Pet Medication Market Analysis and Business Opportunities with CAGR Value, Key Manufactures, Revenue Structure, Types, Applications

The Pet Medication market report gives CAGR value, SWOT Analysis, Industry Chains, Mergers & Acquisitions, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Production, Consumption, Application, Competitor analysis and Forecast.

Dublin, United States - February 12, 2019 /MarketersMedia/ —

Pet medication is the field of medicine that deals with the diagnosis, prevention, and treatment of diseases, injuries, and disorders in pet animals. The market for pet medication displayed impressive growth over the past few years and it has become a vital part of the veterinary industry. Prescription and over-the-counter drugs have witnessed a rapid growth over the past five years. Veterinarians enjoyed the monopoly of prescription and over-the-counter medicines. However, the 90s marked a notable change in the sale of pet medicines when brick & mortar stores and e-commerce started taking over the sale of pet medicines.

The market for pet medication is mainly driven by increasing pet adoption across the globe. There were approximately 90 million pet dogs present in the U.S. in 2017. Changing cultural and socio-economic factors have led to pet animals being considered as an integral member of the family. This has led to a significant increase in pet expenditure. Further, the growing trend of the nuclear family is another major factor responsible for the growth of the pet medication market at present. However, rising prices of pet medicines and rising incidences of pet allergies are some of the factors responsible for the slowdown of the market.

North America and Europe are matured markets for pet medication. High pet adoption in these regions, coupled with frequent launch of new drugs and availability of pet insurance are some of the major factors aiding in the growth of the pet medication market in these regions. However, emerging nations in the Asia-Pacific region are expected to display a higher growth rate for pet medication during the forecast period. The growing base of affluent middle-class population and the willingness to have a reciprocative relationship with pets to fill relationship voids are some of the factors driving market growth for pet medication in the Asia Pacific. China, Japan, and India are expected to lead the growth of the market in the coming years.

The Pet Medication market by Manufacturers: Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences.

Market Segment by Types like Antibiotics, Antifungal, Flea Products and by Application like Cat, Dog, Horse, Fish, Other.

Get Exclusive Sample of Report on Pet Medication market having 108 pages, profiling 16 Leading Market Players https://www.inforgrowth.com/samplerequest/r/341217/global-pet-medication-market-insights-forecast

The report provides information about Pet Medication Market Landscape, Industry History, Development Prospect, Relevant Policy and Trade Overview to current demand, investment and supply in the market. It also shows future opportunities for the forecast years 2018-2025.

Industry chain structure is analyzed by demand of Pet Medication and suppliers along with Cost Analysis, Channel Analysis and technology used for Pet Medication. Market Dynamics gives data about Latest News, Merger and Acquisition of major players, Planned or Future Projects about Pet Medication and Policy Dynamics. Report continues with Import-Export data and country wise market analysis.

The Pet Medication industry development trends are studied through both Secondary and Primary sources. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

 

Major Points from Table of Contents

1 Report Overview

2 Executive Summary

3 Breakdown Data by Manufacturers 

4 Breakdown Data by Type 

5 Breakdown Data by Application 

6 North America 

7 Europe 

8 Asia Pacific 

9 Central & South America 

10 Middle East and Africa 

11 Company Profiles 

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 

13 Value Chain and Sales Channels Analysis 

14 Research Findings and Conclusion 

15 Appendix 

Connect with our expert research team to build custom research on this topic by clicking here https://www.inforgrowth.com/customizationrequest/r/341217/global-pet-medication-market-insights-forecast

Contact Info:
Name: Mr. Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808
Website: https://www.inforgrowth.com/

Source URL: https://marketersmedia.com/pet-medication-market-analysis-and-business-opportunities-with-cagr-value-key-manufactures-revenue-structure-types-applications/481746

Source: MarketersMedia

Release ID: 481746

Latest News

Malaysia's Mahathir says no timetable for handing over power

May 24, 2019

PUTRAJAYA, Malaysia — Malaysian Prime Minister Mahathir Mohamad defended his government's record on the anniversary of its election victory Thursday and reiterated he will hand over power to his successor Anwar Ibrahim though he wasn't clear on when. Mahathir's four-party alliance ousted the coalition that has been in power since independence in 1957 amid anger over then-leader Najib Razak's massive financial scandal and the rising cost of living. But euphoria over the victory has faded and the new government has been accused of backsliding on reform promises in its election manifesto. Mahathir told foreign journalists there had been hiccups in...

Singapore reportedly criminalizes publication of fake news

May 24, 2019

SINGAPORE — Singapore reportedly has passed a law criminalizing publication of fake news and allowing the government to block and order the removal of such content. The Protection from Online Falsehoods and Manipulation Bill passed Wednesday night by a vote of 72-9, a lawmaker with the opposition Worker's Party, Daniel Goh, said on Twitter. The law bans falsehoods that are prejudicial to Singapore or likely to influence elections and requires service providers to remove such content or allows the government to block it. Offenders could face a jail term of up to 10 years and hefty fines. Opponents in Parliament...

Malaysia cuts interest rate for first time in 3 years

May 24, 2019

KUALA LUMPUR, Malaysia — Malaysia's central bank cut interest rates Tuesday for the first time in nearly three years to help support growth and counter risks from a global slowdown, trade tensions and extended weakness in commodity prices. Bank Negara Malaysia says it decided to reduce its overnight policy rate, used by banks to calculate interest rates, to 3% from 3.25%. The rate was last cut by a quarter-basis point to 3% in July 2016, but was raised back to 3.25% in January 2018. The central bank forecast the economy will expand between 4.3-4.8% this year. It said in a...

Boeing 737 Max 8 woes crimp Asian airlines' growth plans

May 24, 2019

SINGAPORE — Asian airlines are cutting routes, revamping their schedules and leasing extra aircraft to fill gaps left by the grounding of Boeing 737 Max 8s after deadly crashes in Indonesia and Ethiopia killed 346 people. So far, regional carriers have managed to avoid major disruptions, but analysts expect that idling the Max 8s, a fuel-efficient update of Boeing's popular 737, will crimp growth plans in the near future. As investigations into the crashes continue, Boeing anticipates a $1 billion increase in costs related to the 737 Max, including fixing software implicated in the disasters, adding pilot training and compensating...

Axiata, Telenor in merger talks to create telecoms giant

May 24, 2019

KUALA LUMPUR, Malaysia — Malaysia's Axiata Group Berhad said Monday it is in talks with Norway's Telenor ASA to merge their Asian operations to create one of the world's top telecommunications giants with some 300 million customers in nine countries. Axiata said in a statement that Telenor is expected to hold a 56.5 percent stake and Axiata 43.5 percent in the proposed "merger of equals." Both companies operate in Malaysia, Thailand, Myanmar, Bangladesh and Pakistan. Axiata also has a presence in India, Sri Lanka, Nepal, Cambodia and Indonesia but it said its Bangladesh operation would be excluded. Axiata said merged...